Insys Therapeutics (INSY) to review strategic alternatives for its portfolio of opioid-related assets
November 5, 2018 4:52 PM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
